Assignee
OCATA THERAPEUTICS INC
US·7 granted patents·5 pending applications·106 citations·filing 2013–2016
Top patents by PatentIndex Score
12 records- 0196US9040039B2Modalities for the treatment of degenerative diseases of the retinaOCATA THERAPEUTICS INC·Filed 2013·Granted May 26, 2015·23 cites·17 claims
- 0295US9730962B2Modalities for the treatment of degenerative diseases of the retinaOCATA THERAPEUTICS INC·Filed 2015·Granted Aug 15, 2017·17 cites·9 claims
- 0395US9193950B2Modalities for the treatment of degenerative diseases of the retinaOCATA THERAPEUTICS INC·Filed 2014·Granted Nov 24, 2015·16 cites·20 claims
- 0495US9181524B2Modalities for the treatment of degenerative diseases of the retinaOCATA THERAPEUTICS INC·Filed 2014·Granted Nov 10, 2015·16 cites·20 claims
- 0595US9040038B2Modalities for the treatment of degenerative diseases of the retinaOCATA THERAPEUTICS INC·Filed 2013·Granted May 26, 2015·17 cites·4 claims
- 0693US10426799B2Methods for production of platelets from pluripotent stem cells and compositions thereofOCATA THERAPEUTICS INC·Filed 2013·Granted Oct 1, 2019·13 cites·32 claims
- 0789US9617512B2Derivation of embryonic stem cells and embryo-derived cellsOCATA THERAPEUTICS INC·Filed 2014·Granted Apr 11, 2017·4 cites·12 claims
- 0856US2015272994A1Mesenchymal stromal cells and uses related theretoOCATA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 0950US2017152481A1Hemangio colony forming cells and non-engrafting hemangio cellsOCATA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1049US2015209126A1Methods for producing pluripotent stem cell-generated embryos, and animals derived therefromOCATA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1149US2015366915A1Pharmaceutical preparations of human rpe cells and uses thereofOCATA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1239US2016175362A1Photoreceptors and photoreceptor progenitors produced from pluripotent stem cellsOCATA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →